Multaq 400 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FULSX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,148
Award facts
- Contract value 100% obligated
- $11,147.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of MULTAQ 400 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $11,147.57. The award was made on October 20, 2025, with an ultimate completion date of October 21, 2025. The contract is a non-set-aside, competitively awarded delivery order, with performance to be executed from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical supply requirements, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The underlying IDC vehicle provides comprehensive global pharmaceutical support enabling AmerisourceBergen to supply the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with a flexible and extensive range of pharmaceutical products and medical commodities.
Quick answers
Who was awarded contract SPE2DB26FULSX?
SPE2DB26FULSX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FULSX worth?
The government has obligated $11,148 on SPE2DB26FULSX.
Is contract SPE2DB26FULSX an order under another contract?
Yes. SPE2DB26FULSX is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB26FULSX competed?
The extent of competition for SPE2DB26FULSX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award